Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn’s disease
Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn’s disease
Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn’s disease